IL6 and hepatocellular carcinoma: The activation of NF-κB signaling and induction of a target gene, Il6, were shown to promote the survival of cancer cells by protecting them against stress-induced cell death during the progression of inflammatory cancers, such as HCC and colitis-associated cancer [31].